Tyrosinase mRNA RT-PCR analysis as an additional diagnostic tool for the identification of melanoma cells in biological fluid samples other than blood: A preliminary report

International Journal of Biological Markers

Volumn 20, Issue 1, 2005, Pages 11-17

  Savoia, P ^a   Quaglino, P ^a   Osella Abate, S ^a   Comessatti, A ^a   Nardo T ^a   Bernengo, Maria Grazia ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Cytology; Immunocytochemistry; Metastatic melanoma; Reverse transcription polymerase chain reaction (RT PCR); Serous membrane effusions; Tyrosinase

Indexed keywords

MELAN A; MESSENGER RNA; MONOPHENOL MONOOXYGENASE; PROTEIN S 100;

ADULT; AGED; ARTICLE; ASCITES; BLOOD SAMPLING; BODY FLUID; CANCER PATIENT; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MALE; MELANOMA CELL; PERICARDIAL EFFUSION; PLEURA EFFUSION; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECURRENT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 18744395000     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2008.1818     Document Type: Article

References (30)

1. Smith B, Selby P, Southgate J, Pittman K, Bradley C, Blair GE. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 1991; 338: 1227-9.
2. Ghossein RA, Coit D, Brennan M, et al. Prognostic significance of peripheral blood and bone marrow tyrosinase messenger RNA in malignant melanoma. Clin Cancer Res 1998; 4: 419-28.
3. Blaheta HJ, Paul T, Sotlar K, et al. Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription-polymerase chain reaction assay in patients with primary cutaneous melanoma: association with Breslow's tumour thickness. Br J Dermatol 2001; 145: 195-202.
4. Osella Abate S, Savoia P, Cambieri I, Salomone B, Quaglino P, Bernengo MG. Role of RT-PCR tyrosinase detection in the monitoring of patients with advanced metastatic melanoma. Melanoma Res 2000; 10: 545-55.
5. Osella-Abate S, Savoia P, Quaglino P, et al. Tyrosinase expression in the peripheral blood of stage III melanoma patients is associated with a poor prognosis: a clinical follow-up study of 110 patients. Br J Cancer 2003; 89: 1457-62.
6. Sears D, Hajdu SI. The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions. Acta Cytol 1987; 31: 85-97.
7. Walts AE. Malignant melanoma in effusions: a source of false-negative cytodiagnosis. Diagn Cytopathol 1986; 2: 150-3.
8. Filho AL, de Carvalho LV, da Cunha Santos G, et al. Cytologic diagnosis of melanoma in serous effusions: a morphologic and immunocytochemical study. Acta Cytol 1995; 39: 481-4.
9. Beaty MW, Fetsch P, Wilder AM, Marincola F, Abati A. Effusion cytology of malignant melanoma. A morphologic and immunocytochemical analysis including application of the MART-1 antibody. Cancer 1997; 81: 57-63.
10. Hoon DS, Kuo CT, Wascher RA, Fournier P, Wang HJ, O'Day SJ. Molecular detection of metastatic melanoma cells in cerebrospinal fluid in melanoma patients. J Invest Dermatol 2001; 117: 375-8.
11. Salomone B, Ponti R, Gasco MR, et al. In vitro effects of cholesteryl butyrate solid lipid nanospheres as a butyric acid pro-drug on melanoma cells: evaluation of antiproliferative activity and apoptosis induction. Clin Exp Metastasis 2000; 18: 663-73.
12. Motherby H, Nadjari B, Friegel P, Kohaus J, Ramp U, Bocking A. Diagnostic accuracy of effusion cytology. Diagn Cytopathol 1999; 20: 350-7.
13. Motherby H, Friedrichs N, Kube M, et al. Immunocytochemistry and DNA-image cytometry in diagnostic effusion cytology. II. Diagnostic accuracyin equivocal smears. Anal Cell Pathol 1999; 19: 59-66.
14. El-Habashi A, El-Morsi B, Freeman SM, El-Didi M, Marrogi AJ. Tumor oncogenic expression in malignant effusions as a possible method to enhance cytologic diagnostic sensitivity. An immunocytochemical study of 87 cases. Am J Clin Pathol 1995; 103: 206-14.
15. Davidson B, Risberg B, Kristensen G, et al. Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers. Virchows Arch 1999; 435: 43-9.
16. Braunschweig R, Yan P, Guilleret I, et al. Detection of malignant effusions: comparison of a telomerase assay and cytologic examination. Diagn Cytopathol 2001; 24: 174-80.
17. Bedrossian CW. Special stains, the old and the new: the impact of immunocytochemistry in effusion cytology. Diagn Cytopathol 1998; 18: 141-9.
18. Fetsch PA, Abati A. Immunocytochemistry in effusion cytology: a contemporary review. Cancer 2001; 93; 293-308.
19. Xu X, Chu AY, Pasha TL, Elder DE, Zhang PJ. Immunoprofile of MITF, tyrosinase, melan-A, and MAGE-1 in HMB45-negative melanomas. Am J Surg Pathol 2002; 26: 82-7.
20. Sheffield MV, Yee H, Dorvault CC, et al. Comparison of five antibodies as markers in the diagnosis of melanoma in cytologic preparations. Am J Clin Pathol 2002; 118: 930-6.
21. Naeyaert JM, Eller M, Gordon PR, Park HY, Gilchrest BA. Pigment content of cultured human melanocytes does not correlate with tyrosinase message level. Br J Dermatol 1991; 125; 297-303.
22. Eberle J, Wagner M, MacNeil S. Human melanoma cell lines show little relationship between expression of pigmentation genes and pigmentary behaviour in vitro. Pigment Cell Res 1998; 11; 134-42.
23. Rios M, Habecker B, Sasaoka T, et al. Catecholamine synthesis is mediated by tyrosinase in the absence of tyrosine hydroxylase. J Neurosci 1999; 19: 3519-26.
24. Battyani Z, Xerri L, Hassoun J, Bonerandi JJ, Grob JJ. Tyrosinase gene expression in human tissues. Pigment Cell Res 1993; 6: 400-5.
25. Cerilli LA, Ritter JH, Mills SE, Wick MR. Neuroendocrine neoplasms of the lung. Am J Clin Pathol 2001; 116: S65-96.
26. Chen YM, Lim BT, Chavin W. Serum tyrosinase in malignant disease, its activity, and the electrophoretic patterns of the enzyme as carried by immunoglobulins. Cancer Res 1979; 39: 3485-90.
27. Rubin DM, Rubin EJ. The possible role of tyrosinase in malignant growth. Med Hypotheses 1983; 10: 469-71.
28. Padmore RF, Lara JF, Ackerman DJ, et al. Primary combined malignant melanoma and ductal carcinoma of the breast. A report of two cases. Cancer 1996; 78: 2515-25.
29. Nobukawa B, Fujii H, Hirai S, et al. Breast carcinoma diverging to aberrant melanocytic differentiation: a case report with histopathologic and loss of heterozygosity analyses. Am J Surg Pathol 1999; 23: 1280-7.
30. Quaglino P, Savoia P, Osella-Abate S, Bernengo MG. RT-PCR tyrosinase expression in the peripheral blood of melanoma patients. Expert Rev Mol Diagn 2004; 4: 727-41.